BroadenBio Co., Ltd.
PrivateLast Round
VC Round
Apr 8, 2022
Company Overview
BroadenBio Co., Ltd. is a biotechnology company that focuses on the research and development of innovative drugs for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BroadenBio Co., Ltd. Comparables
Compare BroadenBio Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elpiscience Biopharmaceuticals | 80% | |
| OncoC4, Inc. | 79% | |
| Oricell Therapeutics | 78% | |
BroadenBio Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 8, 2022 | ||||
| VC Round | Oct 13, 2020 | ||||
| Early Funding | Apr 13, 2020 |
BroadenBio Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | VC Round, Angel |
| Tao Capital Partners | Angel, VC Round |
BroadenBio Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BroadenBio Co., Ltd.'s valuation, stock price, and market status.